AUSTIN, Texas--(BUSINESS WIRE)--MHC Biologics, LLC, an emerging biotechnology company, has developed a unique and proprietary portfolio of breakthrough technologies that can be used in the development and design of anti-cancer and infectious disease treatments for patients worldwide. MHC Biologics, LLC is funded and managed by life sciences venture firm, Emergent Technologies, Inc.
